Evidence map›Paper›PMID 41681966›Full record

ArticleCancers2026

COVID-19 and Influenza Booster Vaccination Elicits Robust Antibody Responses in Patients with Primary Brain Tumors Comparable to Healthy Adults.

Teresa Schmidt, Mirko Trilling, Vu Thuy Khanh Le-Trilling, Lucia Asar, Melanie Fiedler, Christoph Oster, Jana Grieger, Giorgio Cappello, Kathrin Kizina, Leandra Grzib and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Teresa SchmidtDivision of Clinical Neuro-Oncology, Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Mirko TrillingInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.ORCID 0000-0003-3659-3541
Vu Thuy Khanh Le-TrillingInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.ORCID 0000-0002-2733-3732
Lucia AsarInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Melanie FiedlerInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Christoph OsterDivision of Clinical Neuro-Oncology, Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.ORCID 0000-0002-0683-0430
Jana GriegerDivision of Clinical Neuro-Oncology, Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Giorgio CappelloDivision of Clinical Neuro-Oncology, Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Kathrin KizinaDivision of Clinical Neuro-Oncology, Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Leandra GrzibDivision of Clinical Neuro-Oncology, Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Leon JekelDivision of Clinical Neuro-Oncology, Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Björn SchefflerDKFZ-Division of Translational Neurooncology at the West German Cancer Center (WTZ), University Medicine Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Ulrich SureDepartment of Neurosurgery and Spine Surgery, University Hospital Essen, 45147 Essen, Germany.ORCID 0000-0002-9073-1821
Yahya AhmadipourDepartment of Neurosurgery and Spine Surgery, University Hospital Essen, 45147 Essen, Germany.ORCID 0000-0003-3759-8301
Laurèl RauschenbachDKFZ-Division of Translational Neurooncology at the West German Cancer Center (WTZ), University Medicine Essen, University of Duisburg-Essen, 45147 Essen, Germany.ORCID 0000-0001-8348-4298
Christoph KleinschnitzDepartment of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.ORCID 0000-0002-1650-8875
Ulf DittmerInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Martin GlasDepartment of Neurology and Neurooncology, St. Marien Hospital, 44534 Lünen, Germany.
Sied KebirDivision of Clinical Neuro-Oncology, Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 boostergliomahealthy controlhumoral antibody responseimmunogenicityinfluenza boosterprimary brain tumor patients

Identifiers

PMID41681966
PMCPMC12896601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.